MOH — authorised 30 July 2018
- Marketing authorisation holder: ACCORD HLTHCARE
- Status: likely_approved
MOH authorised Torisel on 30 July 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 30 July 2018; MOH authorised it on 16 August 2019.
ACCORD HLTHCARE holds the UAE marketing authorisation.